Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Diseases of the Liver and Gallbladder01:26

Diseases of the Liver and Gallbladder

902
Liver and gallbladder diseases are a significant health concern, with prominent conditions including cirrhosis, hepatitis, non-alcoholic fatty liver disease (NAFLD), and gallstones. Jaundice is a common manifestation of liver and biliary disease.
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
902
Inflammatory Bowel Disease I: Ulcerative Colitis01:27

Inflammatory Bowel Disease I: Ulcerative Colitis

298
Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
298
Esophageal Varices-II: Clinical Features and Management01:28

Esophageal Varices-II: Clinical Features and Management

122
Esophageal varices often manifest as gastrointestinal bleeding episodes, presenting symptoms like hematemesis (vomiting of blood), hematochezia (passing fresh blood via the rectum), and melena (black, tarry stools). Other signs can include weight loss, anorexia, abdominal discomfort, jaundice, pruritus, altered mental status, and muscle cramps.
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
122
Chronic Bowel Disorders: Introduction01:17

Chronic Bowel Disorders: Introduction

527
Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
527
Healthcare Associated Infections I: Iatrogenic, Exogenic and Endogenic01:26

Healthcare Associated Infections I: Iatrogenic, Exogenic and Endogenic

4.4K
Healthcare-associated infections (HAIs) occur in a healthcare facility while a person receives care for another ailment. This category also includes work-related infections among healthcare staff.
HAIs significantly increase the cost of health care. Extended stays in healthcare institutions, increased disability, increased costs of medications, including specialized antibiotics, and prolonged recovery times add to the patient's expenses and the healthcare institution and funding bodies.
4.4K
Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

302
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
302

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Excipients in orally inhaled protein formulations: current examples, challenges, and future directions.

Drug discovery today·2026
Same author

Severity of liver disease is associated with cirrhotic cardiomyopathy: A multicenter study.

Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society·2025
Same author

Triazolyl-phosphine with pyridyl functionality: Pd<sup>II</sup>/Pt<sup>II</sup> complexes and selective transfer semi-hydrogenation of alkynes using ethanol as a hydrogen source.

Dalton transactions (Cambridge, England : 2003)·2025
Same author

Real-time and digital remote nutritional assessment framework with the use of smartphone-enabled facial morphometrics and machine learning- a proof of concept.

European journal of clinical nutrition·2025
Same author

PSLDV-Hop: a robust localization algorithm for WSN using PSO and refinement process.

PeerJ. Computer science·2025
Same author

Ru<sup>II</sup>-amidobis(phosphine) catalyzed alkylation of indole and epoxide opening followed by α-alkylation through alcohol oxidation.

Organic & biomolecular chemistry·2025

Related Experiment Video

Updated: Aug 29, 2025

Histological Analyses of Acute Alcoholic Liver Injury in Zebrafish
10:45

Histological Analyses of Acute Alcoholic Liver Injury in Zebrafish

Published on: May 25, 2017

14.5K

Infections in Alcoholic Hepatitis.

Bhupinder Kaur1, Russell Rosenblatt2, Vinay Sundaram3

  • 1Internal Medicine Department, Cedars-Sinai Medical Center, Los Angeles, CA, USA.

Journal of Clinical and Translational Hepatology
|September 5, 2022
PubMed
Summary

Severe alcoholic hepatitis (sAH) patients face high infection risks due to immune compromise. While corticosteroids are standard treatment, lack of response, not the steroids themselves, increases infection susceptibility, necessitating prompt antibiotic therapy.

Keywords:
Alcoholic hepatitisAlcoholic liver diseaseAntibiotic treatmentAspergillosisCorticosteroidsImmunodeficiencyInfectionsSTOPAH

More Related Videos

"Liver-on-a-Chip" Cultures of Primary Hepatocytes and Kupffer Cells for Hepatitis B Virus Infection
10:25

"Liver-on-a-Chip" Cultures of Primary Hepatocytes and Kupffer Cells for Hepatitis B Virus Infection

Published on: February 19, 2019

11.5K
A Cell Culture Model for Producing High Titer Hepatitis E Virus Stocks
10:28

A Cell Culture Model for Producing High Titer Hepatitis E Virus Stocks

Published on: June 26, 2020

9.8K

Related Experiment Videos

Last Updated: Aug 29, 2025

Histological Analyses of Acute Alcoholic Liver Injury in Zebrafish
10:45

Histological Analyses of Acute Alcoholic Liver Injury in Zebrafish

Published on: May 25, 2017

14.5K
"Liver-on-a-Chip" Cultures of Primary Hepatocytes and Kupffer Cells for Hepatitis B Virus Infection
10:25

"Liver-on-a-Chip" Cultures of Primary Hepatocytes and Kupffer Cells for Hepatitis B Virus Infection

Published on: February 19, 2019

11.5K
A Cell Culture Model for Producing High Titer Hepatitis E Virus Stocks
10:28

A Cell Culture Model for Producing High Titer Hepatitis E Virus Stocks

Published on: June 26, 2020

9.8K

Area of Science:

  • Hepatology
  • Infectious Diseases
  • Critical Care Medicine

Background:

  • Severe alcoholic hepatitis (sAH) patients exhibit immunodeficiency from cirrhosis and corticosteroid use, increasing infection risk.
  • Infections significantly worsen short-term prognosis in sAH patients.
  • Corticosteroids are the primary treatment, but their role in infection risk is debated.

Purpose of the Study:

  • To review common infections and risk factors in sAH.
  • To discuss current diagnostic, therapeutic, and prophylactic strategies for infections in sAH.
  • To clarify the relationship between corticosteroid treatment and infection incidence in sAH.

Main Methods:

  • Literature review of studies on infections in severe alcoholic hepatitis.
  • Analysis of risk factors, diagnostic approaches, and treatment strategies.
  • Synthesis of current evidence regarding corticosteroid use and infection rates.

Main Results:

  • Contrary to previous beliefs, corticosteroids do not appear to increase infection rates in sAH.
  • Lack of response to corticosteroids is a significant factor predisposing sAH patients to infections.
  • Prompt and effective antibiotic treatment is crucial for improving outcomes.

Conclusions:

  • Infections are a major complication in sAH, impacting prognosis.
  • Corticosteroid non-response, rather than use, is linked to increased infection risk.
  • Optimized antibiotic management and prophylaxis are essential for sAH patient care.